Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery
- 15 September 1997
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 27 (2-3), 201-214
- https://doi.org/10.1016/s0169-409x(97)00043-4
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Naringin and naringenin are not the primary CYP3A inhibitors in grapefruit juiceLife Sciences, 1996
- Interaction between tacrolimus and erythromycinThe Lancet, 1994
- Amiodarone-cyclosporine interaction in cardiac transplantationAmerican Heart Journal, 1992
- Lack of Effect of the Calcium Antagonist Isradipine on Cyclosporine Pharmacokinetics in Renal Transplant PatientsTherapeutic Drug Monitoring, 1991
- Reduced cyclosporin accumulation in multidrug-resistant cellsBiochemical and Biophysical Research Communications, 1988
- Interaction Between Erythromycin and Cyclosporine in a Kidney and Pancreas Allograft RecipientTherapeutic Drug Monitoring, 1987
- EXACERBATION OF CYCLOSPORINE TOXICITY BY CONCOMITANT ADMINISTRATION OF ERYTHROMYCINTransplantation, 1987
- Possible Interaction between Cyclosporine and ErythromycinNew England Journal of Medicine, 1986
- Effect of Erythromycin on Cyclosporine LevelsNew England Journal of Medicine, 1985
- RAPID METABOLISM OF CYCLOSPORIN AND PREDNISONE IN KIDNEY TRANSPLANT PATIENT RECEIVING TUBERCULOSTATIC TREATMENTThe Lancet, 1983